Patents by Inventor Brian Connolly

Brian Connolly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250134756
    Abstract: A myofascial device includes a handle having a first end and a second end, a motor at least partially disposed within the handle, a battery at least partially disposed within the handle, and a rotatable assembly disposed between the first end and the second end. The rotatable assembly is configured to rotate during operation of the motor. The rotatable assembly includes a first frame, a second frame, shafts disposed between the first frame and the second frame, first rotatable elements disposed about a first portion of the shafts, and second rotatable elements disposed about a second portion of the shafts.
    Type: Application
    Filed: October 24, 2024
    Publication date: May 1, 2025
    Inventors: Tate Sherman Stock, Reeve Stewart Sudweeks, Jason Lee Walton, Weston N. Hills, Brian Connolly Nielson
  • Publication number: 20250064669
    Abstract: A device includes a first handle formed at least in part by a first housing and a second housing, a second handle formed at least in part by a third housing and a fourth housing, and a rotatable assembly at least partially disposed between the first handle and the second handle. The rotatable assembly is rotatable at least partially about the first housing and the second housing. The rotatable assembly includes shafts, first rotatable elements disposed about a first portion of the shafts, and second rotatable elements disposed about a second portion of the shafts. The first portion of the shafts and the second portion of the shafts are alternatingly disposed around the rotatable assembly.
    Type: Application
    Filed: August 25, 2023
    Publication date: February 27, 2025
    Inventors: Tate Sherman Stock, Reeve Stewart Sudweeks, Mike Hessing, Jason Lee Walton, Weston N. Hills, Brian Connolly Nielson
  • Publication number: 20240091770
    Abstract: The invention provides analyzers that improve tests for detecting specific cellular, viral, and molecular targets in clinical, industrial, or environmental samples. The invention permits efficient and specific selection and sensitive imaging detection of individual microscopic targets at low magnification. Automated embodiments allow efficient walk-away, on-demand, random-access high-throughput testing. The analyzers perform tests without requiring wash steps thus streamlining engineering and lowering costs. Thus, the invention provides analyzers that can deliver rapid, accurate, and quantitative, easy-to-use, and cost-effective tests for analytes.
    Type: Application
    Filed: November 27, 2023
    Publication date: March 21, 2024
    Inventors: Bruce Walsh, Boris Blanter, Matthew Barra, Brian Connolly, Greg Yantz, Paul Gervasio, Don Straus
  • Patent number: 11865534
    Abstract: The invention provides analyzers that improve tests for detecting specific cellular, viral, and molecular targets in clinical, industrial, or environmental samples. The invention permits efficient and specific selection and sensitive imaging detection of individual microscopic targets at low magnification. Automated embodiments allow efficient walk-away, on-demand, random-access high-throughput testing. The analyzers perform tests without requiring wash steps thus streamlining engineering and lowering costs. Thus, the invention provides analyzers that can deliver rapid, accurate, and quantitative, easy-to-use, and cost-effective tests for analytes.
    Type: Grant
    Filed: September 24, 2009
    Date of Patent: January 9, 2024
    Assignee: FIRST LIGHT DIAGNOSTICS, INC.
    Inventors: Bruce Walsh, Boris Blanter, Matthew Barra, Brian Connolly, Greg Yantz, Paul Gervasio, Don Straus
  • Patent number: 11802496
    Abstract: Direct-fired supercritical carbon dioxide (CO2) power cycle that generates hydrogen. More specifically, the discharge of a direct fired supercritical CO2 power cycle is converted to carbon dioxide and hydrogen where the hydrogen and/or carbon dioxide can be separated and stored/utilized in another application.
    Type: Grant
    Filed: March 31, 2022
    Date of Patent: October 31, 2023
    Assignee: SOUTHWEST RESEARCH INSTITUTE
    Inventors: Grant O. Musgrove, Brian Connolly
  • Publication number: 20230313712
    Abstract: Direct-fired supercritical carbon dioxide (CO2) power cycle that generates hydrogen. More specifically, the discharge of a direct fired supercritical CO2 power cycle is converted to carbon dioxide and hydrogen where the hydrogen and/or carbon dioxide can be separated and stored/utilized in another application.
    Type: Application
    Filed: March 31, 2022
    Publication date: October 5, 2023
    Inventors: Grant O. MUSGROVE, Brian CONNOLLY
  • Patent number: 11709925
    Abstract: Embodiments herein describe using visual passwords to control access to secure information. When a user attempts to access the secure information, she can provide her username to an authentication agent which identifies the visual password corresponding to the received username and selects a first set of images that contains the visual password and a second set of images that does not. The first and second sets of images are then transmitted to a user device. The user device can display the first and second sets of images to the user who selects which images have the visual password. An indication of which images the user selected is then transmitted to the authentication engine which determines whether the user selected all the images in the first set and none of the images in the second set. If so, the user is granted access to the secure information.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: July 25, 2023
    Assignee: Amazon Technologies, Inc.
    Inventors: Tristan Bellman-Greenwood, Brian Connolly, Zachary Philip Wilson
  • Patent number: 11377787
    Abstract: The present invention is directed to dye mixtures comprising structures of formula and their production and their use for dyeing textiles and in particular for dyeing aramid fibres.
    Type: Grant
    Filed: December 7, 2017
    Date of Patent: July 5, 2022
    Assignee: DYSTAR COLOURS DISTRIBUTION GMBH
    Inventors: Adrian Murgatroyd, Manfred Hoppe, Clemens Grund, Brian Connolly, Thomas Stepanski
  • Patent number: 11370833
    Abstract: The invention provides stable aqueous pharmaceutical formulations comprising a therapeutic antibody, trehalose, a buffer, and optional surfactant, and having a pH in the range of about 5.5 to about 7.0. The invention also provides methods for making such formulations and methods of using such formulations.
    Type: Grant
    Filed: July 3, 2018
    Date of Patent: June 28, 2022
    Assignee: Genentech, Inc.
    Inventors: Lan Le, Brian Connolly
  • Publication number: 20220040312
    Abstract: The invention provides methods for making such formulations and methods of using such formulations. The invention further provides methods of reducing polysorbate degradation, methods of reducing the amount of visible and sub-visible particles in an aqueous formulation, and methods of disaggregating polysorbate degradation products comprising adding a cyclodextrin to a formula comprising polysorbate and a polypeptide. The invention also provides aqueous formulations comprising a polypeptide, a polysorbate, and a cyclodextrin with reduced polysorbate degradation.
    Type: Application
    Filed: January 22, 2021
    Publication date: February 10, 2022
    Applicant: Genentech, Inc.
    Inventors: Brian CONNOLLY, Lydia HAMBURG, Emily HOLZ
  • Patent number: 10933141
    Abstract: The invention provides methods for making such formulations and methods of using such formulations. The invention further provides methods of reducing polysorbate degradation, methods of reducing the amount of visible and sub-visible particles in an aqueous formulation, and methods of disaggregating polysorbate degradation products comprising adding a cyclodextrin to a formula comprising polysorbate and a polypeptide. The invention also provides aqueous formulations comprising a polypeptide, a polysorbate, and a cyclodextrin with reduced polysorbate degradation.
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: March 2, 2021
    Assignee: GENENTECH, INC.
    Inventors: Brian Connolly, Lydia Hamburg, Emily Holz
  • Patent number: 10869597
    Abstract: Methods, apparatus, and systems are provided for scanning and measuring an anatomical cavity. An apparatus may include an absorbing medium assembly that is fluidly connected to an earpiece and configured to provide an absorbing medium to the earpiece. The absorbing medium assembly may include a medium container with a gas trap, as well as a tube fluidly connected to the medium container. The gas trap may be located at a top portion of the medium container. The tube may be coupled to the top portion or a bottom portion of the medium container. The system may include a dip tube disposed inside the medium container when the tube of the absorbing medium assembly couples to a top portion of the medium container. A gas relief valve configured to enable gas to escape may also be present in the apparatus.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: December 22, 2020
    Assignee: LANTOS TECHNOLOGIES, INC.
    Inventors: Shawn M. Patterson, Steve Schmidt, Mac Andrew Dougan, Brian Connolly, Manas Menon, Lynn Ihlenfeldt
  • Publication number: 20200215195
    Abstract: The invention provides methods for making such formulations and methods of using such formulations. The invention further provides methods of reducing polysorbate degradation, methods of reducing the amount of visible and sub-visible particles in an aqueous formulation, and methods of disaggregating polysorbate degradation products comprising adding a cyclodextrin to a formula comprising polysorbate and a polypeptide. The invention also provides aqueous formulations comprising a polypeptide, a polysorbate, and a cyclodextrin with reduced polysorbate degradation.
    Type: Application
    Filed: November 21, 2019
    Publication date: July 9, 2020
    Applicant: Genentech, Inc.
    Inventors: Brian CONNOLLY, Lydia HAMBURG, Emily HOLZ
  • Patent number: 10525137
    Abstract: The invention provides methods for making such formulations and methods of using such formulations. The invention further provides methods of reducing polysorbate degradation, methods of reducing the amount of visible and sub-visible particles in an aqueous formulation, and methods of disaggregating polysorbate degradation products comprising adding a cyclodextrin to a formula comprising polysorbate and a polypeptide. The invention also provides aqueous formulations comprising a polypeptide, a polysorbate, and a cyclodextrin with reduced polysorbate degradation.
    Type: Grant
    Filed: December 28, 2016
    Date of Patent: January 7, 2020
    Assignee: Genentech, Inc.
    Inventors: Brian Connolly, Lydia Hamburg, Emily Holz
  • Publication number: 20190338461
    Abstract: The present invention is directed to dye mixtures comprising structures of formula and their production and their use for dyeing textiles and in particular for dyeing aramid fibres.
    Type: Application
    Filed: December 7, 2017
    Publication date: November 7, 2019
    Inventors: ADRIAN MURGATROYD, Manfred HOPPE, Clemens GRUND, Brian CONNOLLY, Thomas STEPANSKI
  • Publication number: 20190161541
    Abstract: The invention provides stable aqueous pharmaceutical formulations comprising a therapeutic antibody, trehalose, a buffer, and optional surfactant, and having a pH in the range of about 5.5 to about 7.0. The invention also provides methods for making such formulations and methods of using such formulations.
    Type: Application
    Filed: July 3, 2018
    Publication date: May 30, 2019
    Inventors: Lan LE, Brian Connolly
  • Patent number: 10301475
    Abstract: The invention relates to mixtures of fiber-reactive Triphendioxazine dyes with other fiber-reactive azo dyes and their use for the dyeing of hydroxyl- and especially carboxamide-containing material in blue and navy shades.
    Type: Grant
    Filed: October 26, 2016
    Date of Patent: May 28, 2019
    Assignee: DryStar Colours Distribution GmbH
    Inventors: Adrian Murgatroyd, Manfred Hoppe, Clemens Grund, Brian Connolly, Thomas Stepanski
  • Publication number: 20180230311
    Abstract: The invention relates to mixtures of fibre-reactive Triphendioxazine dyes with other fibre-reactive azo dyes and their use for the dyeing of hydroxyl- and especially carboxamide-containing material in blue and navy shades.
    Type: Application
    Filed: October 26, 2016
    Publication date: August 16, 2018
    Inventors: Adrian MURGATROYD, Manfred HOPPE, Clemens GRUND, Brian CONNOLLY, Thomas STEPANSKI
  • Publication number: 20170189536
    Abstract: The invention provides methods for making such formulations and methods of using such formulations. The invention further provides methods of reducing polysorbate degradation, methods of reducing the amount of visible and sub-visible particles in an aqueous formulation, and methods of disaggregating polysorbate degradation products comprising adding a cyclodextrin to a formula comprising polysorbate and a polypeptide. The invention also provides aqueous formulations comprising a polypeptide, a polysorbate, and a cyclodextrin with reduced polysorbate degradation.
    Type: Application
    Filed: December 28, 2016
    Publication date: July 6, 2017
    Inventors: Brian CONNOLLY, Lydia HAMBURG, Emily HOLZ
  • Patent number: 9445619
    Abstract: Provided herein are exemplary compositions, products, and capsules utilizing POA, EPA, blends of POA and EPA, total algal oil compositions, and/or whole biomass compositions in methods of inhibiting inflammation including in cardiovascular disease, diabetes, obesity, stroke, metabolic syndromes, dementia, Alzheimer's disease, and/or cancer. The exemplary compositions, products, and capsules may be orally, topically, intravenously, and/or subcutaneously administered. The exemplary compositions herein may be used as feed, food, food supplements, beverages, beverage supplements, nutritional products, products for athletic performance, pharmaceutical products, and/or medical products for mammalian use, including humans.
    Type: Grant
    Filed: September 12, 2013
    Date of Patent: September 20, 2016
    Assignee: AURORA ALGAE, INC.
    Inventors: James Astwood, Michelle L. Collins, Brian Connolly